What is CVE-2020-12037?

CVE-2020-12037 is a high-severity vulnerability in Baxter Prismaflex, classified under Use of Hard-coded Password. CVSS score: 7.5/10. Published 2020-06-29.

How severe is CVE-2020-12037?

High severity. CVSS v3 base score is 7.5 out of 10.

Vulnerability in Baxter Prismaflex

CVE-2020-12037

Baxter PrismaFlex all versions, PrisMax all versions prior to 3.x, The affected devices do not implement data-in-transit encryption (e.g., TLS/SSL) when configured to send treatment data to a PDMS (Patient Data Management System) or an EMR (Electronic Medical Record) system. An attacker could observe sensitive data sent from the device.

EPSS: 0.005 (38.9th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 7.5 (High). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N.

Affected products

Baxter Prismaflex
Baxter Prismaflex_firmware
Baxter Prismax
Baxter Prismax_firmware
N/a Baxter Prismaflex And Prismax — versions PrismaFlex all versions, PrisMax all versions prior to 3.x

Weakness classification (CWE)

References

ics-cert@hq.dhs.gov (x_refsource_MISC, Not Applicable)
nvd@nist.gov (Third Party Advisory)

Frequently asked questions

What is CVE-2020-12037?: CVE-2020-12037 is a high-severity vulnerability in Baxter Prismaflex, classified under Use of Hard-coded Password. CVSS score: 7.5/10. Published 2020-06-29.
How severe is CVE-2020-12037?: High severity. CVSS v3 base score is 7.5 out of 10.